marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-14-2024
BioXcel Therapeutics Income Statement 2011-2024 | BTAI
Annual Income Statement BioXcel Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
81.9 M | 78.7 M | 475 M | 1 B | 284 M | 79.9 M | - | - | - | - | - | - | - |
Shares |
29.1 M | 28 M | 26.4 M | 21.7 M | 16.3 M | 14.6 M | - | - | - | - | - | - | - |
Historical Prices |
2.81 | 2.81 | 18.3 | 53.6 | 37.5 | 8.48 | - | - | - | - | - | - | - |
Net Income |
-179 M | -166 M | -107 M | -82.2 M | -33 M | -19.3 M | -4.54 M | -2.12 M | - | - | - | - | - |
Revenue |
1.38 M | 375 K | - | 24.3 | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
1.26 M | 20 K | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | 24.3 | - | - | - | - | - | - | - | - | - |
Operating Income |
-172 M | -160 M | -107 M | -82.3 M | -33.6 M | -20 M | -4.54 M | - | - | - | - | - | - |
Interest Expense |
13.3 M | 8.21 M | 40 K | 27 K | 20 K | - | - | - | - | - | - | - | - |
EBITDA |
-171 M | -159 M | -107 M | -82.1 M | -33.4 M | -19.9 M | -4.54 M | -2.12 M | - | - | - | - | - |
Operating Expenses |
- | - | 107 M | 82.3 M | 33.6 M | 20 M | - | - | - | - | - | - | - |
General and Administrative Expenses |
83.4 M | 68.8 M | 54.2 M | 24.3 M | 7.8 M | 5.4 M | 1.85 M | 721 K | - | - | - | - | - |
All numbers in USD currency
Quarterly Income Statement BioXcel Therapeutics
| 2024-Q3 | 2024-Q2 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
42.4 M | 40.3 M | 29.9 M | 29.3 M | 29.2 M | - | 28.1 M | 28 M | 28 M | 28 M | 28 M | 28 M | 25 M | 24.5 M | 24.4 M | 23 M | 20.3 M | 19 M | 18.1 M | 15.8 M | 15.7 M | 15.7 M | 15.7 M | 15.6 M | 15.6 M | 11.5 M | 9.91 M | 9.48 M | 9.48 M | 9.48 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-13.6 M | -8.3 M | - | -50.5 M | -53.5 M | -52.8 M | - | -41.8 M | -37.7 M | -31.5 M | - | -26.8 M | -27.6 M | -26.4 M | - | -24.8 M | -21.4 M | -14.9 M | - | -9.02 M | -8.47 M | -7.2 M | - | -4.89 M | -3.03 M | -4.28 M | - | -917 K | -565 K | -529 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
214 K | 1.1 M | - | 341 K | 457 K | - | - | 137 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
1.17 M | 62 K | - | 512 K | 26 K | - | - | 11 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-15.3 M | -17.3 M | - | -48.3 M | -52.4 M | - | - | -39 M | -36.3 M | -31.5 M | - | -26.8 M | -27.6 M | -26.4 M | - | -24.8 M | -21.4 M | -15 M | - | -9.13 M | -8.64 M | -7.42 M | - | -5.12 M | -3.24 M | -4.29 M | - | -917 K | -565 K | -529 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
4.82 M | 12 M | - | -5 K | 537 K | - | - | 3.7 M | 1.59 M | 7 K | - | 11 K | 16 K | 7 K | - | 5 K | 12 K | 6 K | - | 18 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-15.2 M | -17.2 M | - | -48.2 M | -52.3 M | - | - | -38.9 M | -36.2 M | -31.4 M | - | -26.7 M | -27.5 M | -26.3 M | - | -24.7 M | -21.4 M | -14.9 M | - | -8.92 M | -8.51 M | -7.38 M | - | -5.11 M | -3.24 M | -4.29 M | - | -916 K | -565 K | -528 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
- | - | - | - | - | - | - | - | 36.3 M | 31.5 M | - | 26.8 M | 27.6 M | 26.4 M | - | 24.8 M | 21.4 M | 15 M | - | 9.13 M | 8.64 M | 7.42 M | - | 5.12 M | 3.24 M | 4.29 M | - | 917 K | 565 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
7.68 M | 9.45 M | - | 24.3 M | 25.9 M | - | - | 17.1 M | 18.4 M | 12.9 M | - | 14.9 M | 14.1 M | 11.6 M | - | 8.45 M | 3.53 M | 2.62 M | - | 2.01 M | 2.13 M | 1.74 M | - | 1.3 M | 1.46 M | 1.35 M | - | 298 K | 241 K | 208 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency